Results 101 to 110 of about 20,409 (197)

A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection. [PDF]

CPT Pharmacometrics Syst Pharmacol
Hanan NJ, Zierhut ML, Nader A, Mahajan A, Kaur A, Kumar K, Dixon SA, Das J, Magee M, Theodore D, Gielen V.   +10 more
europepmc   +1 more source

Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. [PDF]

Hepatol Int
Dong J, Ren S, Wu P, Yu H, Meng X, Zhao J, Ye X, Huang Y, Yu Z, Zhang W, Zeng Y, Wang X, Gao H, Dang S, Li J, Zheng S, Chen X.   +16 more
europepmc   +1 more source

Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis. [PDF]

J Clin Transl Hepatol
Zhang Y, Wang LF, Chen J, Nguyen MH, Zheng Q.   +4 more
europepmc   +1 more source

Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study. [PDF]

Virol J
Zhang W, Chen J, Sun W, Xie N, Tian F, Zhang W, Ruan Q, Song J.   +7 more
europepmc   +1 more source

The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B. [PDF]

Front Immunol
Han J, Xu L, Li Y, Wang Z, Zeng M, Gao J, Mi Y, Kuai W, Xiang H, Xu L.   +9 more
europepmc   +1 more source

Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study. [PDF]

Front Cell Infect Microbiol
Liu H, Gong H, Tan Z, Wu Y, Ran L, Mao Q, Deng G, Jiang L, Xia J.   +8 more
europepmc   +1 more source

Predicting loss of hepatitis B surface antigen and evaluating the durability of functional cure induced by pegylated interferon alpha: insights from a real-world study. [PDF]

PeerJ
Xu X, Huang JQ, Huang S.
europepmc   +1 more source

Lipodystrophy Caused by Repetitive Pegylated Interferon Injection

Internal Medicine, 2013
Numao, Hiroshi, Baba, Masayuki
openaire   +3 more sources

Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B. [PDF]

World J Gastroenterol
Fu YC, Li J, Wang JY, Zhang YW, Yan F, Chen J, Du Q, Yang C, Liang J, Ye Q, Xiang HL.   +10 more
europepmc   +1 more source

Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]

J Virus Erad
Han C, Jin L, Zhu M, Qin Q, Li G, Liu Z, Zhang X.   +6 more
europepmc   +1 more source